Abstract | AIMS: MAIN METHODS: Human prostate cancer cells were exposed to quercetin and TRAIL. Trypan blue assays and terminal transferase dUTP nick-end labeling (TUNEL) assays evaluated changes in TRAIL resistance after quercetin treatment, and flow cytometry examined quercetin-induced death receptor expression in DU-145 cells. Western blotting, reverse transcription-polymerase chain reaction (RT-PCR) and transiently transfection were utilized to confirm apoptotic patterns of prostate cancer cells. KEY FINDINGS: SIGNIFICANCE: Our results showed that the role of quercetin and TRAIL combination therapy may provide a novel strategy for treating prostate cancer by overcoming critical mechanisms of apoptosis resistance.
|
Authors | Young-Hwa Jung, Jeonghoon Heo, Yong J Lee, Taeg Kyu Kwon, Young-Ho Kim |
Journal | Life sciences
(Life Sci)
Vol. 86
Issue 9-10
Pg. 351-7
(Feb 27 2010)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 20096292
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2009 Elsevier Inc. All rights reserved. |
Chemical References |
- Receptors, TNF-Related Apoptosis-Inducing Ligand
- TNF-Related Apoptosis-Inducing Ligand
- Quercetin
|
Topics |
- Apoptosis
(drug effects, physiology)
- Cell Line, Tumor
- Humans
- Male
- Prostatic Neoplasms
(drug therapy, metabolism, pathology)
- Protein Stability
(drug effects)
- Quercetin
(pharmacology, therapeutic use)
- Receptors, TNF-Related Apoptosis-Inducing Ligand
(chemistry, physiology)
- TNF-Related Apoptosis-Inducing Ligand
(physiology, therapeutic use)
- Up-Regulation
(drug effects, physiology)
|